KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AbbVie (ABBV) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to $188.0 million.

  • AbbVie's Net Income towards Common Stockholders fell 8797.95% to $188.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year decrease of 5334.11%. This contributed to the annual value of $4.3 billion for FY2024, which is 1204.6% down from last year.
  • As of Q3 2025, AbbVie's Net Income towards Common Stockholders stood at $188.0 million, which was down 8797.95% from $941.0 million recorded in Q2 2025.
  • In the past 5 years, AbbVie's Net Income towards Common Stockholders registered a high of $4.5 billion during Q1 2022, and its lowest value of -$23.0 million during Q4 2024.
  • In the last 5 years, AbbVie's Net Income towards Common Stockholders had a median value of $1.4 billion in 2024 and averaged $1.8 billion.
  • As far as peak fluctuations go, AbbVie's Net Income towards Common Stockholders soared by 2369411.76% in 2021, and later plummeted by 10279.13% in 2024.
  • AbbVie's Net Income towards Common Stockholders (Quarter) stood at $4.0 billion in 2021, then tumbled by 38.89% to $2.5 billion in 2022, then plummeted by 66.67% to $824.0 million in 2023, then plummeted by 102.79% to -$23.0 million in 2024, then soared by 917.39% to $188.0 million in 2025.
  • Its Net Income towards Common Stockholders was $188.0 million in Q3 2025, compared to $941.0 million in Q2 2025 and $1.3 billion in Q1 2025.